Enter to open, tab to navigate, enter to select
Revance Therapeutics, Inc. follow-on equity offering underwriting agreement of June 18, 2014
| June 18, 2014 • Underwriting Agreements • $122,000,000 |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.